DENEX HTN-KORAS

DENEX HTN-KOrea Regulatory Approval Study is a prospective, multicenter, no-treatment controlled, randomized, open-label, pivotal study to evaluate the Safety and Efficacy of DENEX, Renal Denervation Therapy, in patients with Hypertension on no or 1-3 antihypertensive medications in Korea. Enrollment in DENEX HTN-KORAS began July 2020.

Am I a candidate for the study? If you answered, “YES”, please press the below button to get more information.

• Are you between 19 and 75 years of age?

• Is your blood pressure greater than 140/90 mmHg?

• Would you interested in trying an alternative to medication?

DENEX HTN-EUPILOS

DENEX HTN-EUropean PILOt Study is a prospective, multicenter, sham-controlled, single-blinded, randomized, pilot study to evaluate the safety and efficacy of DENEX system, renal denervation therapy, in patients with hypertension without antihypertensive treatment in Europe. Enrollment in DENEX HTN-EUPILOS will begin September 2022